Nippon Shinyaku Co., Ltd. (4516.T)
JPY 4157.0
(-0.76%)
JPY 4157.0
(-0.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.87 Billion JPY | 7.81% |
| 2022 | 2.66 Billion JPY | -1.81% |
| 2021 | 2.71 Billion JPY | -4.51% |
| 2020 | 2.84 Billion JPY | 40485.71% |
| 2019 | 7 Million JPY | 40.0% |
| 2018 | 5 Million JPY | -37.5% |
| 2017 | 8 Million JPY | -97.12% |
| 2016 | 278 Million JPY | -11.46% |
| 2015 | 314 Million JPY | 0.0% |
| 2014 | - JPY | 0.0% |
| 2013 | - JPY | 0.0% |
| 2012 | - JPY | 0.0% |
| 2011 | - JPY | 0.0% |
| 2010 | - JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 252 Million JPY | -79.86% |
| 2007 | 1.25 Billion JPY | -49.08% |
| 2006 | 2.45 Billion JPY | -33.59% |
| 2005 | 3.7 Billion JPY | -26.25% |
| 2004 | 5.01 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.62 Billion JPY | -8.67% |
| 2023 Q1 | 2.38 Billion JPY | -10.62% |
| 2023 Q4 | 2.87 Billion JPY | 40.23% |
| 2023 Q3 | 2.04 Billion JPY | -6.4% |
| 2023 FY | 2.87 Billion JPY | 7.81% |
| 2023 Q2 | 2.18 Billion JPY | -8.11% |
| 2022 Q1 | 2.59 Billion JPY | -4.35% |
| 2022 Q2 | 2.37 Billion JPY | -8.36% |
| 2022 Q3 | 2.11 Billion JPY | -11.27% |
| 2022 FY | 2.66 Billion JPY | -1.81% |
| 2022 Q4 | 2.66 Billion JPY | 26.26% |
| 2021 Q1 | 324 Million JPY | 8000.0% |
| 2021 Q2 | 324 Million JPY | 0.0% |
| 2021 Q3 | 350 Million JPY | 8.02% |
| 2021 Q4 | 2.71 Billion JPY | 675.14% |
| 2021 FY | 2.71 Billion JPY | -4.51% |
| 2020 FY | 2.84 Billion JPY | 40485.71% |
| 2020 Q1 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 Q4 | 4 Million JPY | 0.0% |
| 2020 Q2 | - JPY | 0.0% |
| 2019 Q1 | - JPY | 0.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2019 FY | 7 Million JPY | 40.0% |
| 2019 Q4 | - JPY | 0.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2018 FY | 5 Million JPY | -37.5% |
| 2018 Q4 | - JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q1 | - JPY | 0.0% |
| 2017 FY | 8 Million JPY | -97.12% |
| 2017 Q2 | - JPY | 0.0% |
| 2017 Q1 | - JPY | 0.0% |
| 2017 Q4 | - JPY | 0.0% |
| 2017 Q3 | - JPY | 0.0% |
| 2016 Q3 | - JPY | 0.0% |
| 2016 Q4 | - JPY | 0.0% |
| 2016 FY | 278 Million JPY | -11.46% |
| 2016 Q1 | - JPY | 0.0% |
| 2016 Q2 | - JPY | 0.0% |
| 2015 FY | 314 Million JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2015 Q4 | - JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2015 Q1 | - JPY | 0.0% |
| 2014 Q3 | - JPY | 0.0% |
| 2014 Q4 | - JPY | 0.0% |
| 2014 Q1 | - JPY | 0.0% |
| 2014 Q2 | - JPY | 0.0% |
| 2014 FY | - JPY | 0.0% |
| 2013 Q4 | - JPY | 0.0% |
| 2013 Q1 | - JPY | 0.0% |
| 2013 Q2 | - JPY | 0.0% |
| 2013 Q3 | - JPY | 0.0% |
| 2013 FY | - JPY | 0.0% |
| 2012 Q3 | - JPY | 0.0% |
| 2012 FY | - JPY | 0.0% |
| 2012 Q4 | - JPY | 0.0% |
| 2012 Q2 | - JPY | 0.0% |
| 2012 Q1 | - JPY | 0.0% |
| 2011 Q1 | - JPY | 0.0% |
| 2011 Q3 | - JPY | 0.0% |
| 2011 FY | - JPY | 0.0% |
| 2011 Q2 | - JPY | 0.0% |
| 2011 Q4 | - JPY | 0.0% |
| 2010 Q1 | - JPY | 0.0% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q4 | - JPY | 0.0% |
| 2010 Q3 | - JPY | 0.0% |
| 2010 Q2 | - JPY | 0.0% |
| 2009 Q2 | 209 Million JPY | 0.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2009 Q3 | 197 Million JPY | -5.74% |
| 2009 FY | - JPY | -100.0% |
| 2008 Q4 | 252 Million JPY | -37.0% |
| 2008 Q3 | 400 Million JPY | 0.0% |
| 2008 FY | 252 Million JPY | -79.86% |
| 2007 FY | 1.25 Billion JPY | -49.08% |
| 2006 FY | 2.45 Billion JPY | -33.59% |
| 2005 FY | 3.7 Billion JPY | -26.25% |
| 2004 FY | 5.01 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 82.997% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.941% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 99.314% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | 75.284% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -2756.887% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | 25.403% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 98.611% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -575.765% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -36.762% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -678.32% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | 77.425% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 83.087% |
| Tsumura & Co. | 79.69 Billion JPY | 96.396% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -66.3% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -1077.049% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 98.581% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 90.079% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 93.965% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 86.289% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | 24.6% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | 67.06% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -4686.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -596.242% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | 69.721% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 96.535% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -214.567% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 90.504% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -1.653% |